Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History $29.88 +0.44 (+1.48%) Closing price 07/3/2025 01:45 PM EasternExtended Trading$30.20 +0.32 (+1.07%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Crinetics Pharmaceuticals Stock Price Performance The Crinetics Pharmaceuticals (CRNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 31.84%, with a year-to-date return of -41.57%. In the past month, the stock has decreased 9.50%, reflecting recent market activity. As of the latest close, Crinetics Pharmaceuticals traded at $29.88 with a market cap of $2.80 billion and volume of 461,098 shares. Five years ago, the stock traded at $16.94, representing a 76.36% increase over that period. At the time, it had a market cap of $556.48 million and a volume of 94,400 shares. Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.08%1 Month Performance-9.50%3 Month Performance+11.10%Year-To-Date Performance-41.57%1 Year Performance-31.84%5 Year Performance+76.36% CRNX Stock Chart for Sunday, July, 6, 2025 CRNX Chart by TradingView Crinetics Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$29.88$29.88$30.24$29.47461,098 shs$2.80 billion07/03/2025$29.44$29.88+1.48%$30.24$29.47461,098 shs$2.80 billion07/02/2025$28.43$29.44+3.55%$30.01$28.41867,380 shs$2.76 billion07/01/2025$28.76$28.43-1.15%$29.24$28.34556,256 shs$2.66 billion06/30/2025$29.96$28.76-4.01%$30.35$28.701.24 million shs$2.69 billion06/27/2025$29.99$29.96-0.10%$30.85$29.591.64 million shs$2.81 billion06/26/2025$30.41$29.99-1.38%$30.40$29.72532,620 shs$2.81 billion06/25/2025$30.94$30.41-1.71%$31.00$29.73556,699 shs$2.85 billion06/24/2025$29.91$30.94+3.44%$31.44$29.85574,500 shs$2.90 billion06/23/2025$30.16$29.91-0.83%$30.69$29.83585,376 shs$2.80 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$30.50$30.16-1.11%$30.86$29.96675,585 shs$2.82 billion06/19/2025$30.50$30.50$31.56$30.42480,466 shs$2.86 billion06/18/2025$30.85$30.50-1.13%$31.56$30.42480,466 shs$2.86 billion06/17/2025$31.20$30.85-1.12%$31.30$30.62539,130 shs$2.89 billion06/16/2025$31.77$31.20-1.79%$32.00$30.94533,605 shs$2.92 billion06/13/2025$32.17$31.77-1.24%$32.13$31.18557,240 shs$2.97 billion06/12/2025$32.33$32.17-0.49%$32.65$31.73678,946 shs$3.01 billion06/11/2025$33.08$32.33-2.27%$33.35$32.30420,639 shs$3.03 billion06/10/2025$32.28$33.08+2.48%$33.77$32.42487,929 shs$3.10 billion06/09/2025$33.01$32.28-2.21%$33.71$32.05489,252 shs$3.02 billion06/06/2025$32.32$33.01+2.13%$33.32$32.50496,611 shs$3.09 billion06/05/2025$32.13$32.32+0.59%$32.84$31.64560,378 shs$3.03 billion Related Companies Qiagen Stock Chart Moderna Stock Chart Ascendis Pharma A/S Stock Chart Viatris Stock Chart Blueprint Medicines Stock Chart BridgeBio Pharma Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Roivant Sciences Stock Chart Elanco Animal Health Stock Chart Revolution Medicines Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
